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For the last 25 years my colleagues and I have been working in Gedarif State on 
endemic diseases. The area is endemic for visceral leishmaniasis, post Kala-azar 
Dermal Leishmaniasis (PKDL) , mucosal leishmaniasis, malaria, measles, leprosy, 
whooping cough, acute upper respiratory infection, malnutrition and diarrhoeal diseases. 
They were the main causes of morbidity and mortality. Although our main mission was 
applied field research on leishmaniasis, we soon recognized that there was far more to 
do than just research. Kala-azar was rife. Sodium stibogluconate (SSG) for treating 
Kala-azar was only available in the hospitals and was sometimes in short supply. A 
black market for SSG was flourishing, the drug was very expensive and it was 
sometimes just water sold as the drug. Parents would buy a few MLs of the drug too 
small to be effective and inject the drug themselves. Due to poor health services we 
worked in collaboration with Ministry of Health and the community, in diagnosing and 
treating several diseases that one meets in a primary health care setting in a poor 
community. Our objective was to introduce simple technology to diagnose these 
diseases early, collect epidemiological data and to treat patients locally as outpatients. 
With the help of MSF Holland we started an applied field research project on the 
epidemiology, diagnosis and management of VL and PKDL. Health education was part 
and parcel of our program. This was in the form of public lectures, small group 
discussions and interaction with individual patients. Drugs for Neglected Diseases 
Initiative (DNDi) came to our help in Sudan and East Africa. DNDi established the 
Leishmaniasis East African Platform (LEAP) between Sudan, Ethiopia, Uganda and 
Kenya to improve on health facilities, develop effective drugs for visceral leishmaniasis 
and train health workers. They established a modern hospital with teaching facilities and 
modern laboratories in Dooka and another in Kassab village in Gedarif State.  Details 
will be given. The changes that occurred in providing health services and in research are 
remarkable and will be detailed in the presentation. 
 
